Weilan Ye - Principal Fellow, Molecular Oncology, Research Biology

Weilan Ye

Principal Fellow, Molecular Oncology, Research Biology

Postdoc Mentor
"Time and again, Genentech is proven to be the industry leader. This is a place where creative minds have a good chance to transform medicine."
Years at Genentech
Publications at Genentech

I came to Genentech as a postdoc in October 1995 to work on neural development and neural degenerative diseases. I enjoyed the dynamic and stimulating scientific environment so much that I decided to stay as a scientist. Beginning in November 1999, I started a small research lab focusing on vascular biology. Today, I am leading a multi-group program working on discovering potential treatments for a variety of diseases with vascular pathologies including exudative age related macular degeneration, diabetic retinopathy, hereditary vascular disorders, and cancer.

Postdoctoral Mentor

One of the most attractive and exciting features of being a scientist at Genentech is to mentor postdocs. Postdocs bring critical thinking, new ideas, and the youthful enthusiasm to our research programs. Mentoring postdocs energizes my mind and fuels my scientific curiosity. I truly enjoy helping them build their careers, and my group finds the postdocs an important part of our working “family”.

Featured Publication

MAP4K4 negatively regulates CD8 T cell–mediated antitumor and antiviral immunity

Science Immunology 27 Mar 2020:Vol. 5, Issue 45, eaay2245

Emel Esen, Ismail Sergin, Rajiv Jesudason, Patricia Himmels, Joshua D. Webster, Hua Zhang, Min Xu, Robert Piskol, Erin McNamara, Stephen Gould, Aude-Hélène Capietto, Lélia Delamarre, Kevin Walsh, and Weilan Ye

The Complexity of Translating Anti-angiogenesis Therapy from Basic Science to the Clinic.

Developmental Cell (April 2016)18;37(2):114-25. doi: 10.1016/j.devcel.2016.03.015.

Weilan Ye